Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...

Add Yahoo as a preferred source to see more of our stories on Google. A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from Cancer Research UK, between 2022 and 2024, around 247 people per 100,000 ...

Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...

A Shropshire hospital trust says patients with prostate cancer are benefitting from greater survival rates thanks to a ...

EAU26: prostate cancer screening compares favourably compared to breast cancer in identifying significant cancers and reducing mortality.

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...